Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.
2 reports, 1 independent
Updated Sep 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- Johnson & Johnson highlighted growth opportunities within the MedTech sector.
- Johnson & Johnson and Recordati Industria Chimica E Farmaceutica are noted as large-cap healthcare companies.
- JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.
- MedTech is identified as a soft spot in J&J case.
- Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.